<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="c9ffa382-0391-4947-9638-dd7d648a6e38"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION, USP safely and effectively. See full prescribing information for PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION, USP.<br/>PHENYLEPHRINE HYDROCHLORIDE ophthalmic solution, USP 2.5% and 10%.<br/>Initial U.S. Approval: 1939</title>
   <effectiveTime value="20250401"/>
   <setId root="cacbb3fd-1c03-4523-a1bf-0ccc4be102ef"/>
   <versionNumber value="3"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="008018525" root="1.3.6.1.4.1.519.1"/>
            <name>Alcon Laboratories, Inc.</name>
            <assignedEntity>
               <assignedOrganization>
                  <id extension="008018525" root="1.3.6.1.4.1.519.1"/>
                  <name>Alcon Laboratories, Inc.</name>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="007672236" root="1.3.6.1.4.1.519.1"/>
                        <name>Alcon Research LLC</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="manufacture"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0065-0349" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="manufacture"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0065-0343" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section ID="ID_7eccd4d4-d43c-4055-9864-f23f9575b6c9">
               <id root="a78ae5e8-286b-468f-9372-35844012cda2"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PRODUCT DATA ELEMENTS SECTION"/>
               <effectiveTime value="20250301"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0065-0349" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Phenylephrine Hydrochloride</name>
                        <formCode code="C60992" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SOLUTION/ DROPS"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Phenylephrine Hydrochloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="25"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="04JA59TNSJ" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Phenylephrine Hydrochloride</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="1WS297W6MV" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>Phenylephrine</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="22ADO53M6F" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Phosphate, Dibasic, Anhydrous</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Phosphate, Monobasic, Anhydrous</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Hydroxide</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="E4GA8884NN" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Phosphoric Acid</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Water</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="F5UM2KM3W7" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Benzalkonium Chloride</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="2"/>
                              <denominator unit="1" value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43171" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, DROPPER"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator unit="1" value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0065-0349-05" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20241028"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="15"/>
                              <denominator unit="1" value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43171" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, DROPPER"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator unit="1" value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0065-0349-04" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20241028"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20150115"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <approval>
                           <id extension="NDA207926" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OPHTHALMIC"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0065-0343" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Phenylephrine Hydrochloride</name>
                        <formCode code="C60992" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SOLUTION/ DROPS"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Phenylephrine Hydrochloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="100"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="04JA59TNSJ" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Phenylephrine Hydrochloride</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="1WS297W6MV" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>Phenylephrine</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="22ADO53M6F" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Phosphate, Dibasic, Anhydrous</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Phosphate, Monobasic, Anhydrous</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Hydroxide</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="E4GA8884NN" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Phosphoric Acid</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Water</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="F5UM2KM3W7" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Benzalkonium Chloride</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="5"/>
                              <denominator unit="1" value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43171" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, DROPPER"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator unit="1" value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0065-0343-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20250430"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20150115"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <approval>
                           <id extension="NDA207926" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OPHTHALMIC"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <component>
                  <observationMedia ID="SPLSERV-86ada506-081f-41bd-9e96-5546eccd31f9">
                     <text>15mL carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="15ml_carton.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM89498">
                     <text>5mL label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="5ml_label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM89499">
                     <text>5mL carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="5ml_carton.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_ccffaf9a-85aa-43dc-a284-7b7220baa9b0">
               <id root="bf161bc9-3780-4c94-87f2-3106eedf9a2d"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10%, is indicated to dilate the pupil.</paragraph>
               </text>
               <effectiveTime value="20250301"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Phenylephrine Hydrochloride Ophthalmic Solution is an alpha-1 adrenergic receptor agonist indicated to dilate the pupil (<linkHtml href="#ID_ccffaf9a-85aa-43dc-a284-7b7220baa9b0">1</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_b0c9cb8a-c4dc-47dc-bbc2-a2a68d86a5de">
               <id root="2e00f178-b564-42b6-b8cd-23ec569eeea0"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION</title>
               <effectiveTime value="20250301"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>
                           <content styleCode="underline">For patients 1 year of age and older</content>: (<linkHtml href="#ID_f30a8248-09e3-466f-87b2-3121a08cdbcf">2.1</linkHtml>)</paragraph>
                        <list listType="unordered" styleCode="Disc">
                           <item>Apply one drop of Phenylephrine Hydrochloride Ophthalmic Solution (2.5% or 10% strength) to conjunctival fornix at 3 to 5 minute intervals up to a maximum of 3 drops per eye.</item>
                           <item>To obtain a greater degree of mydriasis, use 10% strength</item>
                        </list>
                        <paragraph>
                           <content styleCode="underline">For pediatric patients less than 1 year of age</content>: (<linkHtml href="#ID_74033ff5-7a08-48c1-bb1e-4a1775a5c68d">2.2</linkHtml>)</paragraph>
                        <list listType="unordered" styleCode="Disc">
                           <item>Instill one drop of 2.5% strength to conjunctival fornix at 3 to 5 minute intervals up to a maximum of 3 drops per eye</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_f30a8248-09e3-466f-87b2-3121a08cdbcf">
                     <id root="acecc037-7df2-4802-a96c-841bdf2a04ae"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1 General Dosing Recommendations</title>
                     <text>
                        <paragraph>In patients 1 year of age or greater, apply one drop of either phenylephrine hydrochloride ophthalmic solution 2.5% or 10% every 3 to 5 minutes to the conjunctival fornix as required up to a maximum of 3 drops per eye per day.</paragraph>
                        <paragraph>In order to obtain a greater degree of mydriasis, phenylephrine hydrochloride ophthalmic solution 10% may be needed.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_74033ff5-7a08-48c1-bb1e-4a1775a5c68d">
                     <id root="40fc3ccc-6cf6-43a6-bfed-abcf4c0537dc"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2 Dosing in Pediatric Patients Less Than 1 Year of Age</title>
                     <text>
                        <paragraph>In pediatric patients less than 1 year of age, one drop of phenylephrine hydrochloride ophthalmic solution 2.5% should be instilled at 3 to 5 minute intervals up to a maximum of 3 drops per eye.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_ca2bebe9-4155-4cb0-adbd-d47dc13b5617">
               <id root="e6834199-f846-46fa-9d1a-15db4d150700"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS</title>
               <text>
                  <paragraph>Phenylephrine hydrochloride ophthalmic solution, USP 2.5% is a clear, colorless to yellow, sterile topical ophthalmic solution containing phenylephrine hydrochloride 2.5%: each mL contains 25 mg of phenylephrine hydrochloride.</paragraph>
                  <paragraph>Phenylephrine hydrochloride ophthalmic solution, USP 10% is a clear, colorless to yellow, sterile topical ophthalmic solution containing phenylephrine hydrochloride 10%.: each mL contains 100 mg of phenylephrine hydrochloride.</paragraph>
               </text>
               <effectiveTime value="20250301"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Ophthalmic solution (sterile): (<linkHtml href="#ID_ca2bebe9-4155-4cb0-adbd-d47dc13b5617">3</linkHtml>)</paragraph>
                        <list listType="unordered" styleCode="Disc">
                           <item>25 mg of phenylephrine hydrochloride in one mL of solution (2.5%)</item>
                           <item>100 mg of phenylephrine hydrochloride in one mL of solution (10%)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_ef7cb4b7-c96c-41c6-9ca0-9bd20ae072a4">
               <id root="acf619b7-32ba-4ad4-9e18-f592cf543c75"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS</title>
               <effectiveTime value="20250301"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>The 10% strength is contraindicated in:</paragraph>
                        <list listType="unordered" styleCode="Disc">
                           <item>Patients with hypertension, or thyrotoxicosis (<linkHtml href="#ID_143a7117-ab98-45a2-b4fb-d2c7a4ee0f9b">4.1</linkHtml>)</item>
                           <item>Pediatric patients less than 1 year of age due to increased risk of systemic toxicity (<linkHtml href="#ID_b1540b51-c7f2-4e76-a131-fb366896ac54">4.2</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_143a7117-ab98-45a2-b4fb-d2c7a4ee0f9b">
                     <id root="35f43153-670b-49c3-9ef4-2098e28d68d7"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>4.1 Cardiac and Endocrine Disease</title>
                     <text>
                        <paragraph>Phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. Phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_b1540b51-c7f2-4e76-a131-fb366896ac54">
                     <id root="82e414a1-6433-4ca5-b63d-cfc76c73c8e1"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>4.2 Pediatric Patients Less Than 1 Year of Age</title>
                     <text>
                        <paragraph>Phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. Phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients <content styleCode="italics">[See Dosage and Administration (<linkHtml href="#ID_74033ff5-7a08-48c1-bb1e-4a1775a5c68d">2.2</linkHtml>)]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_5d61ae3e-d11c-44b4-b8e7-a3bbf47c4c8d">
               <id root="647c096e-c1d8-44b6-b5d2-9ad67378ba73"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS</title>
               <effectiveTime value="20250301"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>
                              <content styleCode="underline">Not for injection</content>: Topical ophthalmic use only (<linkHtml href="#ID_67692407-e33e-4185-bd84-55ce5fdd1f1a">5.1</linkHtml>)</item>
                           <item>
                              <content styleCode="underline">Serious cardiovascular reactions with 10% strength</content>: Reactions have included ventricular arrhythmias and some have been fatal.  Monitor blood pressure in patients with cardiovascular disease (<linkHtml href="#ID_d006115c-996d-48a2-b8ac-07712cc52f4a">5.2</linkHtml>).</item>
                           <item>
                              <content styleCode="underline">Significant elevations in blood pressure</content>:  Caution in pediatric patients less than 5 years of age, and in patients with cardiovascular disease or hyperthyroidism.  In patients at high risk, monitor blood pressure post treatment (<linkHtml href="#ID_d67fda5a-0073-4717-8a45-e20043bcdc65">5.3</linkHtml>).</item>
                           <item>
                              <content styleCode="underline">Rebound miosis</content>: Reported one day after instillation (<linkHtml href="#ID_eed081a7-02e3-47b3-a69f-52865c4b1148">5.4</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_67692407-e33e-4185-bd84-55ce5fdd1f1a">
                     <id root="b368fcad-1b1d-4890-80e6-f3929308c571"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1 Topical Ophthalmic Use Only</title>
                     <text>
                        <paragraph>Phenylephrine hydrochloride ophthalmic solution 2.5% and 10% is not indicated for injection.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_d006115c-996d-48a2-b8ac-07712cc52f4a">
                     <id root="b5b74bea-cc7d-404f-9353-497523447737"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2 Cardiovascular Reactions</title>
                     <text>
                        <paragraph>There have been reports of serious cardiovascular reactions, including ventricular arrhythmias and myocardial infarctions, in patients using phenylephrine 10%. These episodes, some fatal, have usually occurred in patients with pre-existing cardiovascular diseases. Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% should be used in these patients.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_d67fda5a-0073-4717-8a45-e20043bcdc65">
                     <id root="85e6a2ea-6bc6-4579-8ec2-169b4c4cf94d"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3 Elevation of Blood Pressure</title>
                     <text>
                        <paragraph>A significant elevation in blood pressure is not common but has been reported following conjunctival instillation of recommended doses of phenylephrine 10%. The risk is less with phenylephrine 2.5%. Caution should be exercised with the use of phenylephrine 10% in pediatric patients less than 5 years of age and patients with hyperthyroidism, or cardiovascular disease. The post-treatment blood pressure of patients with cardiac and endocrine diseases and any patients who develop symptoms should be carefully monitored.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_eed081a7-02e3-47b3-a69f-52865c4b1148">
                     <id root="5afa2988-c229-454a-9760-0baf86272a35"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.4 Rebound Miosis</title>
                     <text>
                        <paragraph>Rebound miosis has been reported one day after receiving phenylephrine hydrochloride ophthalmic solution, and re-instillation of the drug produced a lesser mydriatic effect.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_09943da6-5214-40be-849f-84d62881c1e7">
               <id root="6d7dbb6a-b783-4e51-b492-8e9b01a65894"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The following serious adverse reactions are described below and elsewhere in the labeling:</paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Cardiovascular Effects [<content styleCode="italics">See Warnings and Precautions (<linkHtml href="#ID_d006115c-996d-48a2-b8ac-07712cc52f4a">5.2</linkHtml>
                        </content>)]</item>
                     <item>Elevation in Blood Pressure [<content styleCode="italics">See Warnings and Precautions (<linkHtml href="#ID_d67fda5a-0073-4717-8a45-e20043bcdc65">5.3</linkHtml>
                        </content>)]</item>
                  </list>
                  <paragraph>The following adverse reactions have been identified following use of phenylephrine hydrochloride ophthalmic solution. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</paragraph>
               </text>
               <effectiveTime value="20250301"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>Ocular adverse reactions include eye pain and stinging on instillation, temporary blurred vision, and photophobia (<linkHtml href="#ID_df4dcb27-6b4e-4295-b8db-44f266ed163b">6.1</linkHtml>)</item>
                           <item>Cardiovascular adverse reactions include increase in blood pressure, syncope, myocardial infarction, tachycardia, arrhythmia and subarachnoid hemorrhage (<linkHtml href="#ID_d1baab3c-1b72-439d-b32b-6839fad518d5">6.2</linkHtml>)</item>
                        </list>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact <content styleCode="bold">Alcon Laboratories</content> at 1-800-<content styleCode="bold">757-9195</content> or FDA at 1-800-FDA-1088 or <content styleCode="italics">
                                 <linkHtml href="https://www.fda.gov/medwatch">www.fda.gov/medwatch</linkHtml>
                              </content>
                           </content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_df4dcb27-6b4e-4295-b8db-44f266ed163b">
                     <id root="b4fe3f11-8c28-4b24-a902-abe63cb9b94a"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>6.1 Ocular Adverse Reactions</title>
                     <text>
                        <paragraph>Eye pain and stinging on instillation, temporary blurred vision and photophobia, and conjunctival sensitization may occur.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_d1baab3c-1b72-439d-b32b-6839fad518d5">
                     <id root="102b029a-6e46-44cf-b9ac-6bacd6733d5a"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>6.2 Systemic Adverse Reactions</title>
                     <text>
                        <paragraph>A marked increase in blood pressure has been reported particularly, but not limited to low weight premature neonates, infants and hypertensive patients.</paragraph>
                        <paragraph>Cardiovascular effects which have been seen primarily in hypertensive patients following topical ocular use of phenylephrine hydrochloride ophthalmic solution 10% include marked increase in blood pressure, syncope, myocardial infarction, tachycardia, arrhythmia and subarachnoid hemorrhage [<content styleCode="italics">See Warnings and Precautions (<linkHtml href="#ID_d006115c-996d-48a2-b8ac-07712cc52f4a">5.2</linkHtml> and <linkHtml href="#ID_d67fda5a-0073-4717-8a45-e20043bcdc65">5.3</linkHtml>
                           </content>)].</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_bf3f9f00-ef65-4b8d-b4f8-9d8ac0b601ac">
               <id root="2accd5ff-4bfa-446f-b6bb-e3890dcda08b"/>
               <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
               <title>7 DRUG INTERACTIONS</title>
               <effectiveTime value="20250301"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>
                              <content styleCode="underline">Atropine-like drugs</content>:  May exaggerate the adrenergic pressor response (<linkHtml href="#ID_c53a8123-1bd6-47bb-b07e-3a69a7d0f5a3">7.1</linkHtml>)</item>
                           <item>
                              <content styleCode="underline">Potent inhalation anesthetic agents</content>:  May potentiate cardiovascular depressant effects (<linkHtml href="#ID_c53a8123-1bd6-47bb-b07e-3a69a7d0f5a3">7.1</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_c53a8123-1bd6-47bb-b07e-3a69a7d0f5a3">
                     <id root="385cf7c0-d2cd-46f1-a3f8-16e242a91c3f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.1 Agents That May Exaggerate Pressor Responses</title>
                     <text>
                        <paragraph>Concomitant use of phenylephrine and atropine may enhance the pressor effects and induce tachycardia in some patients. Phenylephrine may potentiate the cardiovascular depressant effects of some inhalation anesthetic agents.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_8c595120-10d0-4f75-a9c1-7a949799c8fd">
               <id root="fc86baf0-607c-4aba-a2d6-1b39eefe1e02"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS</title>
               <effectiveTime value="20250301"/>
               <component>
                  <section ID="ID_a703c438-d2fa-4062-b284-6c1b44cbfd51">
                     <id root="9956c58a-5fbd-4aa3-be88-eed628f68764"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy</title>
                     <text>
                        <paragraph>Animal reproduction studies have not been conducted with topical phenylephrine. It is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_cfd552d7-52df-4f32-9eaa-9cd08f6a5bad">
                     <id root="69d23bff-878b-49a7-9f13-a0e135417af5"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title>8.3 Nursing Mothers</title>
                     <text>
                        <paragraph>It is not known whether this drug is excreted in human breast milk. Because many drugs are excreted in human milk, caution should be exercised when phenylephrine hydrochloride ophthalmic solution 2.5% and 10% is administered to a nursing woman.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_d11cec77-27f1-4355-b4b0-98dba7903ff9">
                     <id root="862e83d8-ee37-4687-a607-6e1af2478e4c"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use</title>
                     <text>
                        <paragraph>Phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age [<content styleCode="italics">See Contraindications (<linkHtml href="#ID_b1540b51-c7f2-4e76-a131-fb366896ac54">4.2</linkHtml>)</content>].</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_9eb834b0-d85e-4b2e-ab16-f811c6173bfe">
                     <id root="fdebd2d1-196d-4107-ac62-e83842c64f6a"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use</title>
                     <text>
                        <paragraph>No overall differences in safety and effectiveness have been observed between elderly and younger adult patients.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_5733c8d9-4419-4cef-b754-d9affbfe3dfa">
               <id root="10f312a3-b69e-4e73-a244-c60be40973d0"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>10 OVERDOSAGE</title>
               <text>
                  <paragraph>Overdosage of phenylephrine may cause a rapid rise in blood pressure. It may also cause headache, anxiety, nausea, and vomiting, and ventricular arrhythmias. Prompt injection of a rapidly acting alpha-adrenergic blocking agent such as phentolamine has been recommended.</paragraph>
               </text>
               <effectiveTime value="20250301"/>
            </section>
         </component>
         <component>
            <section ID="ID_e9b898f6-e053-4ad4-ba73-1b8a9d0c1ec2">
               <id root="67d98311-89d9-4ad9-a105-4dc810fddd99"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION</title>
               <text>
                  <paragraph>Phenylephrine Hydrochloride Ophthalmic Solution, USP is a sterile, clear, colorless to yellow, topical α-adrenergic agonist for ophthalmic use. The active ingredient is represented by the chemical structure</paragraph>
                  <renderMultiMedia ID="SPLSERV-09f212fc-2b31-4c75-ba5a-a18bafe22094" referencedObject="SPLSERV-32a8e761-70d2-4942-8e1f-b2c575b602a2"/>
                  <paragraph>Chemical Name: (R)-3-hydroxy-α[(methylamino)methyl]benzenemethanol hydrochloride.</paragraph>
                  <paragraph>Molecular Formula: C<sub>9</sub>H<sub>13</sub>NO<sub>2</sub>.HCl</paragraph>
                  <paragraph>Molecular Weight: 203.67 g/mol</paragraph>
                  <paragraph>Each mL of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% contains: ACTIVE: Phenylephrine Hydrochloride 25 mg (2.5%); INACTIVES: Sodium Phosphate Monobasic, Sodium Phosphate Dibasic, Water for Injection. Phosphoric Acid and/or Sodium Hydroxide may be added to adjust pH (4.0 to 7.5). The solution has a tonicity of 340 mOsm/kg; PRESERVATIVE: Benzalkonium Chloride 0.1 mg (0.01%).</paragraph>
                  <paragraph>Each mL of Phenylephrine Hydrochloride Ophthalmic Solution, USP 10% contains: ACTIVE: Phenylephrine Hydrochloride 100 mg (10%); INACTIVES: Sodium Phosphate Monobasic, Sodium Phosphate Dibasic, Water for Injection. Phosphoric Acid and/or Sodium Hydroxide may be added to adjust pH (4.0 to 7.5). The solution has a tonicity of 985 mOsm/kg; PRESERVATIVE: Benzalkonium Chloride 0.1 mg (0.01%). </paragraph>
               </text>
               <effectiveTime value="20250301"/>
               <component>
                  <observationMedia ID="SPLSERV-32a8e761-70d2-4942-8e1f-b2c575b602a2">
                     <text>Chemical Structure</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="phe05-0008-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_81db558f-61af-4080-a5c6-5699f81e9e7c">
               <id root="5455d317-bb3e-4e4e-8de5-544c24b7ddfb"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY</title>
               <effectiveTime value="20250301"/>
               <component>
                  <section ID="ID_edcb816e-a82a-4567-8a32-5fd667b7d9f5">
                     <id root="5093a949-e4f1-47c5-ae66-d14747996dec"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action</title>
                     <text>
                        <paragraph>Phenylephrine hydrochloride is an α-1 adrenergic agonist drug that is used in ophthalmology mainly for its mydriatic effect. After topical application to the conjunctiva, phenylephrine acts directly on α-adrenergic receptors in the eye, producing contraction of the dilator muscle of the pupil and constriction of the arterioles in the conjunctiva.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_931e16bd-af3e-477f-adfb-c143c2bc2a03">
                     <id root="8d4946b8-3260-4a8a-8bf8-e5ae531d025a"/>
                     <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                     <title>12.2 Pharmacodynamics</title>
                     <text>
                        <paragraph>Maximal mydriasis occurs in 20 to 90 minutes with recovery after 3 to 8 hours.</paragraph>
                        <paragraph>Systemic absorption of sufficient quantities of phenylephrine may lead to systemic α-adrenergic effects, such as rise in blood pressure which may be accompanied by a reflex atropine-sensitive bradycardia.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_d878d013-8832-4e61-a42a-d829f051c4d6">
                     <id root="17e1ab9f-9f50-4053-97cc-3623e02081ce"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics</title>
                     <text>
                        <paragraph>The systemic exposure following topical administration of phenylephrine hydrochloride ophthalmic solution has not been studied. A higher systemic absorption is expected for the 10% solution than the 2.5% solution and when the corneal barrier function is compromised.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_37f6ed6b-9852-48cc-8f64-16b08674c32e">
               <id root="8a4511b6-30ce-4d8d-a09d-e0c770189d31"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14 CLINICAL STUDIES</title>
               <text>
                  <paragraph>Pupillary dilation following topical administration of phenylephrine hydrochloride ophthalmic solution has been demonstrated in controlled clinical studies in adults and pediatric patients with different levels of iris pigmentation. Pupil movement is generally seen within 15 minutes, maximal mydriasis between 20 to 90 minutes and recovery after 3 to 8 hours. Darker irides tend to dilate slower than lighter irides.</paragraph>
               </text>
               <effectiveTime value="20250301"/>
            </section>
         </component>
         <component>
            <section ID="ID_d9c4f64d-4c6e-4e4b-9125-45b7725986b0">
               <id root="dc8639b7-94ce-4eab-921c-ce282c476266"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING</title>
               <text>
                  <paragraph>Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% is supplied as a sterile, aqueous, topical ophthalmic solution in an opaque, white low density polyethylene (LDPE) bottle with a natural LDPE dropper tip and red cap in the following sizes:</paragraph>
                  <paragraph>NDC 0065-0349-05         2 mL in 4 mL bottle<br/>NDC 0065-0349-04         15 mL in 15 mL bottle</paragraph>
                  <paragraph>Phenylephrine Hydrochloride Ophthalmic Solution, USP 10% is supplied as a sterile, aqueous, topical ophthalmic solution in an opaque, white low density polyethylene (LDPE) bottle with a natural LDPE dropper tip and red cap in the following sizes: </paragraph>
                  <paragraph>NDC 0065-0343-02         5 mL in 8 mL bottle</paragraph>
                  <paragraph>After opening, Phenylephrine Hydrochloride Ophthalmic Solution, USP can be used until the expiration date on the bottle.</paragraph>
               </text>
               <effectiveTime value="20250301"/>
               <component>
                  <section ID="ID_5dc216e5-5760-4d36-b82a-2d33d35c49d7">
                     <id root="3873259f-80da-4464-a35f-0363a68d758f"/>
                     <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Storage:</content> Store at 20°C to 25°C (68°F to 77°F).</paragraph>
                        <paragraph>Keep container tightly closed.</paragraph>
                        <paragraph>Protect from light and excessive heat.</paragraph>
                        <paragraph>Do not use if solution is brown or contains precipitate.</paragraph>
                     </text>
                     <effectiveTime value="20250301"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_de1f4703-9c25-4e5e-b2aa-f3e3e90d4d45">
               <id root="aeba7acb-c202-43b2-865c-9203b1422d5d"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17. PATIENT COUNSELING INFORMATION</title>
               <text>
                  <paragraph>Advise patients not to touch the dropper tip to any surface as this may contaminate the solution. Inform patients that they may experience sensitivity to light and should protect their eyes in bright illumination while their pupils are dilated.</paragraph>
                  <paragraph>Distributed by: <content styleCode="bold">ALCON LABORATORIES, INC.<br/>
                     </content>Fort Worth, Texas 76134 U.S.A.</paragraph>
               </text>
               <effectiveTime value="20250301"/>
            </section>
         </component>
         <component>
            <section ID="ID_9c640ce0-2016-4e34-ab1e-ceaceef769ec">
               <id root="ad2fde48-0721-4dcc-9847-b8ff935667e8"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>Principal Display Panel Text for Container Label:</paragraph>
                  <paragraph>
                     <content styleCode="bold">Phenylephrine Hydrochloride<br/> Ophthalmic Solution, USP</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">2.5%</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Sterile<br/> Rx only</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Alcon</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">2mL</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">NDC 0065-0349-05</content>
                     <br/>
                     <content styleCode="bold">Each mL contains: Active: </content>
                     <br/>Phenylephrine Hydrochloride (2.5%) <br/>
                     <content styleCode="bold">Storage:</content> Store at 20ºC-25ºC (68ºF-77ºF).<br/>
                     <content styleCode="bold"> Dosage:</content> see Prescribing Information<br/>
                     <content styleCode="bold">ALCON LABORATORIES, INC.</content>
                     <br/>Fort Worth, Texas 76134 USA<br/>
                     <br/>LOT:               EXP.:<br/>
                     <br/>300066881-0924</paragraph>
                  <renderMultiMedia ID="SPLSERV-63a6386e-ea4f-44fd-b76d-f0bb644a0a87" referencedObject="SPLSERV-611d135b-75e4-46b4-8089-ead58c68d3de"/>
               </text>
               <effectiveTime value="20250301"/>
               <component>
                  <observationMedia ID="SPLSERV-611d135b-75e4-46b4-8089-ead58c68d3de">
                     <text>2mL label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="2ml_label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_2f44616c-9fa9-4323-85fe-5e476e1ffbdd">
               <id root="dfed4be1-39ce-4c16-bf08-9896e611c751"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>Principal Display Panel Text for Carton Label:</paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only <br/>Sterile</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">NDC 0065-0349-05</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Phenylephrine<br/> Hydrochloride <br/>Ophthalmic<br/> Solution, USP 2.5%</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">FOR TOPICAL APPLICATION IN THE EYE</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">2mL</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Alcon</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Each mL contains:</content>
                     <br/>
                     <content styleCode="bold"> Active:</content> Phenylephrine <br/>Hydrochloride 25 mg (2.5%);<br/>
                     <content styleCode="bold"> Inactives:</content> Sodium Phosphate<br/> Dibasic, Sodium Phosphate<br/> Monobasic, Sodium Hydroxide<br/> and/or Phosphoric Acid may be<br/> added to adjust pH (4.0 to 7.5)<br/> and Water for Injection q.s.;<br/>
                     <content styleCode="bold"> Preservative:</content> Benzalkonium<br/> Chloride 0.1 mg (0.01%).<br/>
                     <br/>
                     <content styleCode="bold">Dosage</content>: see Prescribing <br/>Information.<br/>
                     <content styleCode="bold"> Storage:</content> Store at 20ºC to 25ºC<br/> (68ºF to 77ºF). Keep tightly <br/>closed. Protect from light and<br/> excessive heat.<br/> Do not use if solution is<br/> brown or contains a<br/> precipitate.<br/>
                     <br/>
                     <br/>KEEP OUT OF REACH OF<br/> CHILDREN.<br/>
                     <br/> DO NOT USE IF IMPRINTED<br/> SEAL IS BROKEN OR MISSING.<br/>
                     <br/>
                     <content styleCode="bold">ALCON LABORATORIES, INC.</content>
                     <br/> 6201 South Freeway<br/> Fort Worth, Texas 76134 USA<br/> 1-800-757-9195<br/> alcon.medinfor@alcon.com<br/> Printed in USA<br/>
                     <br/>300066873-0924<br/>
                     <br/>
                     <content styleCode="bold">SN:<br/>LOT:<br/>EXP.:<br/>GTIN:</content> 00300650349055<br/>
                  </paragraph>
                  <renderMultiMedia ID="SPLSERV-066c1853-7646-4226-a34a-9fcfb637e689" referencedObject="SPLSERV-27b64e46-ea6e-42e2-8e04-644fef2818be"/>
               </text>
               <effectiveTime value="20250301"/>
               <component>
                  <observationMedia ID="SPLSERV-27b64e46-ea6e-42e2-8e04-644fef2818be">
                     <text>2mL carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="2ml_carton.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_6dac28fe-befc-441c-8866-52b745c0e78f">
               <id root="d0eadd16-18c4-4a95-af11-e34f2d5c941f"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>Principal Display Panel Text for Container Label:</paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 0065-0349-04</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">15mL</content>
                     <br/>
                     <br/>300066880-0924<br/>
                  </paragraph>
                  <renderMultiMedia ID="SPLSERV-3f9d73ee-8d53-403d-bb7b-ffd05a9cb78e" referencedObject="SPLSERV-b23c0d6b-825a-4be2-a747-135b4c2ea7a2"/>
               </text>
               <effectiveTime value="20250301"/>
               <component>
                  <observationMedia ID="SPLSERV-b23c0d6b-825a-4be2-a747-135b4c2ea7a2">
                     <text>15mL label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="15ml_label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_5a94334a-e6a1-4da1-88c0-bd7d59e4fab4">
               <id root="174c81e8-47ad-45ab-8c98-1dfde4b8b418"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>Principal Display Panel Text for Carton Label:</paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 0065-0349-04</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">15mL</content>
                     <br/>
                     <br/>300066872-0924<br/>
                     <br/>
                     <content styleCode="bold">SN: <br/>LOT: <br/>EXP.: <br/>GTIN:</content> 00300650349048<br/>
                  </paragraph>
                  <renderMultiMedia referencedObject="SPLSERV-86ada506-081f-41bd-9e96-5546eccd31f9"/>
                  <paragraph>Principal Display Panel Text for Container Label: <br/>
                     <br/>
                     <content styleCode="bold">NDC 0065-0343-02</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Phenylephrine<br/> Hydrochloride <br/>Ophthalmic<br/> Solution, USP </content>
                     <br/>
                     <br/>
                     <content styleCode="bold">10%</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">FOR TOPICAL APPLICATION<br/> IN THE EYE</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Sterile Rx <br/>only </content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Alcon</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">5 mL</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">Each mL contains: Active: </content>
                     <br/>Phenylephrine Hydrochloride (10%);<br/>
                     <content styleCode="bold"> Inactives:</content> Sodium<br/> Phosphate Dibasic, Sodium <br/>Phosphate Monobasic, Sodium<br/> Hydroxide and/or Phosphoric Acid<br/> may be added to adjust pH (4.0 to<br/> 7.5) and Water for Injection q.s.;<br/>
                     <content styleCode="bold"> Preservative:</content> Benzalkonium <br/>Chloride 0.1 mg (0.01%).<br/>
                     <br/>
                     <br/>
                     <content styleCode="bold">Dosage:</content> see Prescribing<br/> Information. <br/>
                     <content styleCode="bold">Storage:</content> Store at 20ºC to 25ºC <br/>(68ºF to 77ºF). Keep container<br/> tightly closed. Do not use if<br/> solution is brown or contains a <br/>precipitate. <br/>
                     <content styleCode="bold">DO NOT USE IF IMPRINTED <br/>SEAL IS BROKEN OR MISSING. </content>
                     <br/>
                     <br/>
                     <content styleCode="bold">ALCON LABORATORIES, INC. </content>
                     <br/>Fort Worth, Texas 76134 USA<br/>
                     <br/>LOT:                        EXP.:<br/>
                     <br/>30006 7943-0225</paragraph>
                  <renderMultiMedia referencedObject="MM89498"/>
                  <paragraph>Principal Display Panel Text for Carton Label: <br/>
                     <br/>
                     <content styleCode="bold">NDC 0065-343-02<br/>
                        <br/>KEEP OUT OF REACH OF<br/>CHILDREN</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">ALCON LABORATORIES, INC.</content>
                     <br/>6201 South Freeway<br/>Fort Worth, Texas 76134 USA<br/>1-800-757-9195<br/> alcon.medinfor@alcon.com <br/>Printed in USA<br/>
                     <br/>SN:<br/>LOT:<br/>EXP.:<br/>GTIN: 00300650343022<br/>
                     <br/>300067876-0225</paragraph>
                  <renderMultiMedia referencedObject="MM89499"/>
               </text>
               <effectiveTime value="20250301"/>
            </section>
         </component>
      </structuredBody>
   </component>
</document>